Project Grant R21NS142497

Award Date 6/1/25
Completion Date 5/31/27
Dollars Obligated $428K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $233,250 to the University of North Carolina at Chapel Hill to develop and evaluate a highly sensitive luciferase-based biosensor that can quantify endogenous UBE3A ubiquitin ligase activity in cells and the brain. The biosensor will be used to measure aberrant UBE3A...
Emory University received a $430,375 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to elucidate the subcellular dynamics of ubiquitination, a key biological process regulating synaptic function and neuronal health, using advanced single-molecule imaging techniques. The research aims to uncover new mechanisms by...
This $528,129 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to structurally and functionally characterize critical ubiquitinating and de-ubiquitinating enzymes implicated in human diseases. The overarching goal is to develop a detailed understanding of how ubiquitin-proteasome pathway (UPP) components recognize substrates and execute their function, which is crucial for developing new...
This federal Project Grant award in the amount of $390,000.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research into the roles of protein ubiquitination and deubiquitination in neurological disorders. Specifically, the research aims to determine how the E3 ubiquitin ligase RNF216 and the deubiquitinase OTUD4 interact to...
This $443,121 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the University of California, Santa Cruz in conducting innovative research to understand dysregulated protein synthesis, or translation, in an autism spectrum disorder (ASD) model. The project aims to leverage cutting-edge cryo-electron microscopy (cryo-EM)...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $438,342 to the University of California, San Diego (UCSD) to study the fundamental mechanisms by which ubiquitin ligases recognize and ubiquitinate substrates within protein complexes. The research aims to illuminate the role of the Anaphase-Promoting Complex (APC)...
This $164,998 federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to elucidate the role of parvalbumin-positive (PV+) neurons in seizure susceptibility in a mouse model of Angelman syndrome. The research aims to determine how the intrinsic firing properties of PV+ neurons in the dentate gyrus differ between Angelman syndrome model mice and...
The University of Wisconsin System was awarded a $427,625 Project Grant under the National Institute on Aging's Aging Research program (CFDA 93.866) to develop a conditional, humanized mouse model for studying Ubiquilin 2 (UBQLN2)-associated Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). The proposed research aims to generate the UBQLN2 mouse model, evaluate its neurodegenerative phenotypes, and utilize it to investigate disease pathways related to ALS/FTD caused by...
This $145,642 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate mRNA regulation during synaptogenesis in the nematode C. elegans. The study will leverage high-resolution imaging and mass spectrometry techniques to characterize the dynamics of the essential presynaptic gene syd-2/liprin-alpha and identify novel...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $608,787 to the University of California, San Diego (UCSD) to investigate a novel mechanism of dysfunctional mitophagy and the excessive accumulation of damaged mitochondria after cerebral ischemia. The research aims to determine if inactivation of the...

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $427,625 Project Grant (CFDA 93.853) to the University of Wisconsin-Madison to profile the cell type-specific ubiquitome in Ube3a mutant mice. The goal is to systematically identify differentially ubiquitinated proteins, potentially Ube3a substrates, in excitatory and inhibitory neurons at different developmental stages. By using a specialized Cre-dependent ubiquitin tagging mouse line, the researchers will visualize cell type-specific and age-specific ubiquitination of Ube3a substrates and generate comprehensive ubiquitome profiles. This work aims to elucidate Ube3a's varying functions across cell types and ages, enhancing understanding of its role in Angelman syndrome and advancing towards effective treatments. The award period is from June 1, 2025 to May 31, 2027.

Generated 6/17/25, 4:50 AM